baber/WOPTO huggingface dataset:
Patent IL-73188-A0 (IL)
Title: Synthetic resin wound dressing and method of treatment using same
IPC: A61F13/00
Filed: 1984-10-08
Abstract: An apparatus and method is described for applying epidermal growth factor (EGF) for achieving healing enhancement at a wound site. The human source of epidermal growth factor, designated as hEGF, is applied from the synthetic resin matrix system of this invention, and which comprises a polymer, such as poly(2-hydroxyl ethyl methyl methacrylate), referred to as PHEMA, an organic solvent, such as polyethylene glycol (PEG), and a hydrogen binding plasticizer, such as dimethylsulfoxide (DMSO). The plasticizer regulates the set-up time of the synthetic resin, so that the more plasticizer present, the shorter the set-up time. The dressing, once formed, and having the healing enhancer contained therein, may be sealed within various backing sheets, in order to preserve its aseptic condition. When ready for use, one of the backing sheets may be peeled away to expose the resin pad with the embodied healing enhancer, ready for application to the wound site.
Patent IL-80039-A0 (IL)
Title: Method and system for tinting contact lenses
IPC: B41M1/30
Filed: 1986-09-16
Abstract: A method of tinting soft contact lenses (L) uses at least one transfer-pad printer (2) including a suitable ink of the desired tint, and at least one printing block (6) carrying an iris pattern. The contact lenses are attached to lens mounts (14), preferably by being shrunk onto curved heads (18) of the mounts, and are then aligned, in turn, with the pad (4) of the transfer-pad printer (2). For each lens, the printing block (6) is inked, the pad is caused to pick up the iris pattern from the inked block, and the pad is then caused to make contact with the mounted lens, thereby transferring the iris pattern as picked up from the block to the mounted contact lens. Apparatus for carrying out the method is also described.
Patent AU-PS049002-A0 (AU)
Title: Methods and apparatus (ap50)
IPC: B41K1/40
Filed: 2002-02-13
Abstract: A stamp includes a compressible housing having an upper housing portion telescopically receiving a lower housing portion, the lower housing portion defining an aperture at a lower end thereof substantially spanning a width of the lower housing portion; a printhead and ink cartridge arrangement housed within the lower housing, the printhead displaceable from a protected position within the housing to traverse the aperture of the lower housing portion; a mechanical arrangement comprising a pair of arms fixed at one end to a top of the printhead and at another end to the upper housing, the arms acting on the printhead in accordance with a movement of the upper housing portion with respect to the lower housing to effect traversal of the printhead from the protected position across the aperture; and a spring engaged at one end with the printhead and engaged at another end with the lower housing, the spring for returning the printhead to the protected position.
Patent FI-20001542-A0 (FI)
Inventor: WANECEK MICHAEL
IPC: A61K9/48
Filed: 2000-06-29
Abstract: Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been mentioned for the treatment of congestive heart failure, is useful in the treatment of septic shock.
Patent FI-20010114-A0 (FI)
Inventor: VANHANEN JUHA PETTERI
IPC: G06Q30/00
Filed: 2001-01-18
Abstract: A method in connection with power plants connected to form a network, the network comprising a central unit (1) and the power plants (2) comprising a measurement and control unit, wherein the central unit comprises time series models of the power plants connected to form the network, the method comprising the steps of collecting (3) measurement data to the central unit from the power plants connected thereto; storing (5) the measurement data in a database of the central unit; updating (7) the power-plant-specific time series models stored in the central unit; drawing up (8) at the central unit power-plant-specific forecasts of the energy need on the next time period; retrieving (9) price information relating to the next time period from energy exchanges, or the like, to the central unit; computing (11) at the central unit optimum power levels for the generating units on the basis of load and price forecasts; and transmitting (12) control commands to the generating units.
Patent FI-20030929-A0 (FI)
Inventor: KALLIO JANNE
IPC: H04B7/005
Filed: 2003-06-19
Abstract: An emulator functionality is provided at both ends of a satellite communication link that is used between wireless network cells inside a vehicle, such as an aircraft, and a terrestrial communication system. The emulator is capable of providing required state signalling without a connection between a base station of the wireless network inside the vehicle and a base station controller of the terrestrial communication system. In accordance with an exemplary embodiment of the invention the satellite communication link can be switched to an off-state when it is not needed for transferring calls or other information. A further non-limiting exemplary embodiment of the invention provides for a use of alternative satellite connections depending on the location of the vehicle is provided.
Patent IL-111791-A0 (IL)
Title: Glutaramide derivatives
IPC: A61P43/00
Filed: 1994-11-28
Abstract: The present invention relates to a crystalline, alpha-polymorphic form of a compound of formula (I) and to processes for the preparation of, to intermediates used in the preparation of, to compositions containing and to uses of, the alpha-polymorphic form.
Patent IL-114141-A0 (IL)
Title: Method for preparing cloud stable extract
IPC: A23L2/52
Filed: 1995-06-14
Abstract: PCT No. PCT/DK95/00224 Sec. 371 Date Dec. 4, 1996 Sec. 102(e) Date Dec. 4, 1996 PCT Filed Jun. 7, 1995 PCT Pub. No. WO95/34223 PCT Pub. Date Dec. 21, 1995A method of producing cloud stable extracts such as juices from plant material by using one or more enzymes that attack the hairy regions of pectin.
Patent IL-119696-A0 (IL)
Title: Optically active beta-aminoalcohols and process for their production
IPC: C07C67/31
Filed: 1996-11-26
Abstract: 1. An optically active  beta -aminoalkoxyborane complex of the formula (I):    <IMAGE>  (I)  wherein R1 is C1-C8 alkyl, C3-C7 cycloalkyl, C7-C11 aralkyl or C6-C10 aryl, R2 is hydrogen, C1-C8 alkyl, C3-C7 cycloalkyl or C7-C11 aralkyl, or R1 and R2 together form (CH2)n wherein n is 3 or 4, and Ar is naphthyl, anthryl or phenanthryl, which may be substituted by from 1 to 3 substituents selected from the group consisting of halogen, nitro, C1-C6 alkyl, C3-C7 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C7-C11 aralkyl, C6-C10 aryl, C1-C6 alkoxy and styrene polymer substituents.
Patent IL-124426-A0 (IL)
Title: Method and apparatus for expressing body fluid from an incision
IPC: A61B5/151
Filed: 1997-05-16
Abstract: A fluid sampling apparatus includes a housing member (1) which contains a lancing needle (16) used for piercing skin together with a spring member (11) for urging the needle to protrude form the housing end sufficient to penetrate the skin. A plunger (14) retracts the needle against the spring tension and a trigger member (2) engages the plunger to hold the needle retracted until released by the trigger. Stop and adjustment tabs (19) limit the depth of needle penetration of the skin and a sample container communicating with the needle receives the sample from the needle. Secondary springs retract the needle from the skin and a suction cam and plunger (22) activated upon retraction of the needle draws the sample of fluid which accumulates on the surface of the skin into the sample container.
Patent IL-133250-A0 (IL)
Title: Dose setting device
IPC: A61M/
Filed: 1998-06-15
Abstract: A dose setting device for a delivery system has a piston rod (6, 9) which successively presses a piston (2) into a cylinder ampoule (1). Doses are set by rotating a second part (9) of the piston rod (6, 9) in relation to a first part (6). The two parts are connected by mating threads so that the total length of the piston rod (6, 9) is increased proportional to the angle of rotation, and a point (18) on the second part is moved away from a stop position fixed in relation to a housing (5) The set dose is delivered when the point (18) is moved back to the stop position. The first part (6) can be axially displaced but not rotated in the housing (5), and the second part (9) can both rotate and be axially displaced. The first part (6) is maintained in abutment with the piston (2) and the second part (9) is coupled to be rotated by a dose setting wheel (20). An injection push button (10) is movable between a projecting position and a pressed home position and has elements (13) acting on the second part (9) to press this part to its stop position.
Patent IL-136015-A0 (IL)
Title: Agents for combating neospora spec
IPC: A61K45/00
Filed: 1998-11-20
Abstract: The invention relates to agents for combating protozoan diseases caused by the Neospora species. The inventive agents are characterised in that they contain one or more active constituents which inhibit the microtubulin system of plants.
Patent IL-136835-A0 (IL)
Title: Utilization of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
IPC: A61K31/22
Filed: 1998-12-08
Abstract: The use of one or several alkyl hydrogen fumarates of the general formulawherein R is a C1-5 alkyl, optionally in admixture with dialkyl fumarate of the formulaand optionally customary pharmaceutical excipients and carriers for preparing a pharmaceutical composition in the form of micro-tablets or micro-pellets for treating psoriasis, psoriatic arthritis, neurodermatitis and enteritis regionalis Crohn.
Patent IL-144026-A0 (IL)
Title: Phenylphenanthridine derivatives and pharmaceutical compostions containing the same
IPC: A61P17/16
Filed: 2000-01-12
Abstract: Compounds of the formula I,   
in which R1, R2, R3, R31, R4, R5, R51, R6, R13 and R20 have the meanings indicated in the description, are novel active bronchial therapeutics.
Patent IL-155760-A0 (IL)
Title: Purified active hcv ns2/3 protease
IPC: G01N33/68
Filed: 2001-12-13
Abstract: A method for producing a refolded, inactive form of recombinantly produced NS2/3 protease which comprises the steps of: a) purifying the protease from inclusion bodies in the presence of a chaotropic agent; and b) refolding the purified protease by contacting it with a reducing agent and lauryldiethylamine oxide (LDAO) in the presence of reduced concentration of chaotropic agent or polar additive. The invention further comprises a method for activating this refolded inactive NS2/3 protease by adding an activation detergent. This method produces large amounts of the active NS2/3 protease to allow small molecules and ligands to be screened as potential inhibitors of NS2/3 protease, which may be useful as therapeutic agents against HCV.
Patent IL-159592-A0 (IL)
Title: Closure device with a piercing element
IPC: B65D5/74
Filed: 2002-06-10
Abstract: A closing device arranged above a pierceable point of a closed container including a lower part with a cylindrical discharge nozzle, a screw cover and a piercing element. The piercing element, which is open on both sides, is displaced downwards in an axial direction in a screw-like manner in a screw cover in the lower part of the closing device. The piercing element has two cutting elements offset at an angle which produce a continuous, interconnected cutting line, and a displacing element which shifts a partially cut-out tab of the container from a region of the discharge nozzle.
Patent IL-159762-A0 (IL)
Title: Ammonia-free alkaline microelectronic cleaning compositions with improved substrate compatibility
IPC: C11D3/32
Filed: 2002-07-08
Abstract: Ammonia-free cleaning compositions for cleaning microelectronic substrates, and particularly to such cleaning compositions useful with and having improved compatibility with microelectronic substrates characterized by sensitive porous dielectrics, low-k or high-k dielectrics and copper metallization. Cleaning compositions for stripping photoresists, cleaning residues from plasma generated organic, organometallic and inorganic compounds, and cleaning residues from planarization processes. The cleaning composition contain one or more non-ammonium producing strong base containing non-nucleophilic, positively charged counter ions and one or more corrosion inhibiting solvent compounds, said corrosion inhibiting solvent compound having at least two sites capable of complexing with metals.
Patent IL-162349-A0 (IL)
Title: Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives
IPC: A61K31/34
Filed: 2002-12-02
Abstract: The present invention concerns processes for the preparation of each of the 4 diastereomers of formula (I) in stereochemically pure form from either of two enantiomerically pure precursors. The tetracyclic ringsystem having trans-fused five and seven membered rings is formed in an acid-catalysed cyclization reaction. The invention further relates to the thus obtained cis-fused tetracyclic alcohol intermediates, the methanamine end-products, the methanamine end-products for use as a medicine, in particular as CNS active medicines.
Patent IL-178714-A0 (IL)
Title: Vapor phase catalytic chlorination of ??-picoline
IPC: C07D213/16
Filed: 2006-10-18
Abstract: 2-Chloro-5-trichloromethylpyridine is obtained by chlorinating beta-picoline in the vapor phase using a Mordenite zeolite or a supported palladium catalyst.
Patent IL-183550-A0 (IL)
Title: Cyclopropanation process
Filed: 2007-05-30
Abstract: A process for the cyclopropanation of a substituted alkene, comprising the reaction of the alkene with a carbenoide, generated from dibromomethane and a tri-(C2-C8)-alkyl aluminium compound, in the presence of a catalytic amount of a metal compound selected from the group consisting of Lewis acids, metallocenes and metal carbonyl complexes. The process advantageously uses transition metal compounds as catalysts and the dibromomethane can be recovered. The process is especially useful for the preparation of ingredients for the flavour and fragrance industry.
Patent IL-189536-A0 (IL)
Title: System and method for managing the visual effects insertion in a video stream
Filed: 2008-02-14
Abstract: A method and system are presented for use in real-time insertion of visual effects in a video stream. At least one reference image is used that contains a region of interest, which is to be involved in the video stream. the reference image is processed by defining a set of at least a few reference features therein, and inserting the visual effects into the reference image with a desired orientation of the visual effects with respect to the region of interest in the reference image. Successive video frames are grabbed in a sequence of a few video frames, and at least one of video frames is used as at least one snapshot image. The snapshot image(s) is/are process by selecting therein at least two from the reference features and determining a reference transformation between the snapshot image and the reference image. Independently of this processing of the snapshot image, the snapshot image and other video frames are processed to determine a sequence of transformations between them. These data are utilized to determine an operative transformation between the reference image and either one of the video frames, thereby enabling real-time management of the appearance of the visual effects in the video stream by using the operative transformation for the insertion of the visual effects in other video frames.
Patent IL-190801-A0 (IL)
Title: Therapeutic combination of amlodipine and benazepril/benazeprilat
IPC: A61K45/06
Filed: 2008-04-10
Abstract: The present invention especially relates to the use of a combination comprising  (1) an ACEI selected from the group consisting of benazepril, benazeprilat, and pharmaceutically acceptable salts thereof, and  (2) amlodipine or pharmaceutically acceptable salt thereof,  
for the manufacture a medicament for the treatment or prevention or delay of progression of a condition selected from the group consisting of hypertension, congestive heart failure, angina, myocardial infarction, artherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, blood pressure-related cerebrovasular disease, stroke, pulmonary disease or pulmonary hypertension and headache; 
wherein  (i) the amount of amlodipine or a pharmaceutically acceptable salt thereof corresponds to 6 mg to 40 mg of the free base and  (ii) the amount of the ACE inhibitor or a pharmaceutically thereof corresponds to 20 mg to 160 mg of benazepril hydrochloride.
Patent IL-248539-A0 (IL)
Title: High-purity large scale preparation of stannsoporfin
Filed: 2016-10-27
Abstract: Large scale (bulk) compositions comprising high-purity stannsoporfin are disclosed, as well as methods of synthesizing such compositions.
Patent RO-133218-A0 (RO)
Title: Gyroscopically stabilized positioning system meant to fit out mobile terrestrial and air means
Inventor: VASILE ALEXANDRU
IPC: H02P6/14
Filed: 2018-09-20
Abstract: The invention relates to an electronic control circuit for the brushless direct current motors (BLDC) for gyroscopically stabilized positioning systems. According to the invention, the circuit allows speed modification by pulse-width modulation (PWM) at a frequency much higher than the motor frequency and the reduction of parasitic signals by means of a Kalman filter.
Patent RO-134412-A0 (RO)
Title: Optimal control system for autonomous locomotives asynchronous traction motors, based on the control of sliding frequency
Inventor: BITOLEANU ALEXANDRU
IPC: H02P23/08
Filed: 2020-01-15
Abstract: The invention relates to a system for controlling autonomous locomotives asynchronous traction motors, based on the control of the sliding frequency. According to the invention, the system contains a closed-circuit regulation part, consisting of two loops connected in a cascade arrangement, namely a subordinate loop for adjusting the effective value of the current absorbed by the motor, consisting of blocks (4, 5, 6 and 11) and a main speed control loop consisting of blocks (1, 2, 3 and 15), and an open-circuit regulation part for calculating the inverter control frequency, consisting of blocks (7, 8, 9, 10, 12), wherein the prescribed stationary speed is applied to the block (1) which converts the step signal into a ramp signal with a rising speed equal to the imposed acceleration, then it is compared with the actual speed measured with a transducer, in a comparator whose output is the speed error.
Patent MC-2260-A1 (MC)
Inventor: JAIME SIMON
IPC: A61K51/12
Filed: 1991-06-11
Abstract: Radiopharmaceutical formulations for complexes comprising at least one radionuclide complexed with a ligand, or its physiologically-acceptable salts thereof, especially <1><5><3>samarium-ethylenediaminetetramethylenephosphonic acid, which optionaily contains a divalent metal ion, e.g. calcium, and is frozen, thawed, and then administered by injection. Alternatively, the radiopharmaceutical formulations must contain the divalent metal and are frozen only if the time before administration is sufficiently long to cause concern for radiolysis of the ligand.
Patent MA-27794-A1 (MA)
Title: Dihydroquinazolines substituees a proprietes antivirales
Inventor: WUNBERG TOBIAS
IPC: C07D239/84
Filed: 2005-11-08
Abstract: Dihydroquinazolines substituées à propriétés antivirales L'invention se rapporte à des dihydroquinazolines substituées et aux procédés de leur préparation et également à leur utilisation dans la préparation de médicaments pour le traitement et/ou la prophylaxie des maladies, en particulier pour leur utilisation comme agents antiviraux, en particulier contre les cytomégalovirus.
Patent MA-37949-A1 (MA)
Title: Polypeptides contenant fc ayant une glycosylation modifiée et une fonction effectrice réduite
Inventor: PAN CLARK
IPC: C07K16/28
Filed: 2013-09-12
Abstract: L'invention concerne des polypeptides de liaison (par exemple des anticorps) et des conjugués médicamenteux de ceux-ci, comportant un domaine fc ayant un profil de glycosylation modifié et une fonction effectrice réduite. Dans un mode de réalisation particulier, le domaine fc comporte : un résidu asparagine à la position d'acide aminé 298, selon la numération eu; un résidu sérine ou thréonine à la position d'acide aminé 300, selon la numération eu. L'invention concerne également des acides nucléiques codant pour les polypeptides de liaison à un antigène, des vecteurs d'expression recombinants et des cellules hôtes pour la fabrication de tels polypeptides de liaison à un antigène. L'invention concerne également des procédés d'utilisation des polypeptides de liaison à un antigène selon la présente invention pour traiter une maladie.
Patent MA-44424-A1 (MA)
Title: Membrane flexible composite à mémoire de forme, programmable destinée au prototypage rapide en quatre dimensions
Inventor: Ennaji Mohammed
IPC: C22F1/00
Filed: 2018-12-31
Abstract: La présente invention concerne un nouveau dispositif de prototypage rapide en quatre dimensions. Il est constitué d’une membrane composite déformable à mémoire de forme, réutilisable et programmable. Cette membrane, composée de fibres à base d’alliages à mémoire de forme, est elle même la matière et le dispositif permettant la réalisation du prototype de forme quelconque. Ces fibres conductrices à mémoire de forme sollicitées par injection de courant électrique au niveau de chacune d’elle génèrent des déformations instantanées de la membrane et par la suite le prototype.
Patent UY-24146-A1 (UY)
Title: Carne procesada , material alimenticio cárneo usando la misma y método de producción para la carne procesada
Inventor: KATAYAMA HIROSHI
IPC: A23B4/02
Filed: 1996-01-10
Abstract: El propósito de esta invención es el de proveer carne procesada que tiene un alto valor nutritivo que es tierna, elástica, que es capaz de ser procesada en la forma requerida, que está libre de pérdida por deterioro y que tiene un alto rendimiento, en donde se utilizan nutrientes de bajo peso molecular como el jugo de goteo de la carne. La carne procesada de esta invención comprende; un contenido de sal de 0,2 a 5 partes en peso, preferentemente de 0,3 a 4 partes en peso y más preferentemente de 0,5 a 2,5 partes en peso y un contenido de álcali de 0,1 a 0,6 partes en peso, preferentemente de 0,3 a 0,4 partes en peso y más preferentemente de 0,5 a 2 partes en peso por cada 100 partes en peso.
Patent UY-25258-A1 (UY)
Title: Combinación de un inhibidor de la aldosa reductasa y un inhibidor de la glucógeno fosforilasa.
Inventor: TREADWAY
IPC: A61P9/00
Filed: 1998-11-19
Abstract: Composiciones farmacéuticas de combinación y procedimientos que incluye inhibidores de la aldosa reductosa e inhibidores de la glucógeno fosforilasa. Las composiciones y procedimientos son útiles para el tratamiento de afecciones resistentes a insulina; tales como la diabetes, y para reducir las lesiones tisulares debidas a isquemia. Por ejemplo el compuesto zopolrestat, ácido ftalazinoacético,3,4-dihidro-4-oxo-3-((5-8trifluorometil)-2-benzotiazolil9metil), esteinhibidor de la aldoreductasa, es útil en el tramamiento de diabetes Ejemplo: ácido 3-(4-bromo-2-fluorobencil)-3,4-dihidro-4-oxo-1-ftalazinoacético.